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AIM(S) (1) to describe the course of fatigue over a 3-year follow-up period in adults with 15 
cerebral palsy (CP); and (2) to investigate the association of known determinants of fatigue 16 
(i.e. demographic characteristics and/or body composition) with change in fatigue.  17 
METHOD Forty-one adults with CP from a previous study examining fatigue were invited to 18 
participate in a follow-up study. Twenty-three adults with CP (GMFCS levels I-V; mean age 19 
38y 2m, standard deviation [SD 14y 1m]) agreed to participate (convenience sample). 20 
Fatigue was measured with the Fatigue Impact and Severity Self-Assessment (FISSA, range 21 
31 to 157) questionnaire. The course of fatigue is described at group, subgroup (GMFCS) 22 
and individual levels. 23 
RESULTS The mean (SD) FISSA score for all participants was 84.0 (27.7) at baseline and 24 
91.7 (26.7) at follow-up. Despite variations among individuals in the change of fatigue, there 25 
was no statistically significant difference in FISSA score over time (p=0.087, 95% CI -16.7 to 26 
1.22). We did not find any known determinants of fatigue to be predictive of change in FISSA 27 
scores. 28 
INTERPRETATION Fatigue appears to be relatively stable within adults with CP over time, 29 
with a variable presentation between individuals and across GMFCS levels. Care providers 30 
should monitor and discuss fatigue with young individuals with CP to attenuate fatigue later 31 
in life. 32 
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Introduction 41 
 42 
Fatigue is a term used to describe a reduced capacity to sustain power output over time, and 43 
is the experience of feeling tired, weak, or lacking energy.1 There is growing recognition that 44 
fatigue is a common problem in adults with cerebral palsy (CP).2–4 Findings from one study 45 
documented that 41% of adults with bilateral CP were severely fatigued (Fatigue Severity 46 
Scale [FSS] ³5.1).2 Russchen et al.5 found that adults with bilateral CP were more at risk for 47 
high levels of fatigue than unilaterally affected adults. However, in a different study, 30% of 48 
participants experienced substantial fatigue (Fatigue Questionnaire [FQ]), regardless of 49 
topographical distribution of CP.4  50 
CP is defined as “a group of permanent disorders of the development of movement and 51 
posture, causing activity limitation, that is attributed to non-progressive disturbances that 52 
occurred in the developing fetal or infant brain”.6 Although CP is a non-progressive disease, 53 
individuals with CP experience a number of secondary health conditions that occur as they 54 
age.5,7–11 Young adults with CP described fatigue as a new experience that emerges in 55 
adulthood.7,11 Furthermore, adults with CP report functional deterioration;12 increasing pain;13 56 
and reduced participation in sports and social activities14 with increasing age.  57 
It is of great importance to improve our knowledge about fatigue experienced by individuals 58 
with CP as they age, because of the association of fatigue with bodily pain, deterioration of 59 
functional skills, and low life-satisfaction in individuals with CP.4 Individuals with CP need to 60 
know whether their fatigue is likely to improve, stay the same or get progressively worse over 61 
time to plan their future. Healthcare providers need to know the factors associated with 62 
change in fatigue, if any, to inform surveillance, prevention, and management. 63 
To our knowledge, there is only one published longitudinal study on fatigue in adults with 64 
CP.9 This 7-year follow-up study concluded that fatigue did not change, as measured using 65 
the FQ, for adults with CP (n=149), Gross Motor Function Classification System (GMFCS)15 66 
level I-IV. However, these results need to be interpreted with caution due to some limitations 67 
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in the study. First, the study was not specifically designed to measure fatigue over time. 68 
Second, the authors used the FQ and the FSS, both of which have not been validated for 69 
individuals with CP. Finally, they did not include individuals who were GMFCS level V, a 70 
subgroup that is often not included in clinical research. A recent follow-up study in adults with 71 
CP (GMFCS levels I-V)16 described longitudinal changes in perceived health, presence of 72 
health issues and functional level in adults with CP. They concluded pain and severe fatigue 73 
(dichotomized as a FSS ³5.1) to be the most common health issues in 31 adults with CP and 74 
found them to be predictive of perceived poor health.  75 
McPhee et al.3 measured fatigue in adults with CP using the Fatigue Impact and Severity 76 
Self-Assessment (FISSA), which is validated for use with adults with CP.17 They concluded 77 
that participants experienced at least some fatigue across all levels of the GMFCS. Also, 78 
they discovered a significant negative relationship between moderate-to-vigorous physical 79 
activity (MVPA) per hour and FISSA scores, meaning higher levels of MVPA were associated 80 
with decreased levels of fatigue. Furthermore, a significant positive relationship between BMI 81 
and FISSA scores was discovered, meaning that increased fatigue was experienced in 82 
people with a higher BMI.3 To our understanding, no one has assessed fatigue over time in 83 
adults with CP using a tool that has been validated for this population.  The primary objective 84 
of the current study is to describe the course of fatigue over a 3-year follow-up period in 85 
adults with cerebral palsy (CP) using the FISSA. The secondary objective is to investigate 86 
the association between possible, previously identified, determinants of fatigue (i.e. 87 
demographic characteristics [including age, distribution of CP and community ambulation] 88 
and/or body composition [i.e. BMI and waist circumference (WC)]) and change in fatigue.   89 
Method 90 
Participants 91 
This study is part of a larger on-going program of research of cardiovascular health and 92 
physical activity in adolescents and adults with CP: the Stay-FIT research program at 93 
CanChild, McMaster University (www.canchild.ca).18 Participants who took part in the cross-94 
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sectional study by McPhee et al. were contacted and invited to participate in this study. Our 95 
study sample is a convenience sample. Persons with CP were eligible for inclusion if they 96 
met each of the following criteria: ≥18 years of age and able to respond to questions with 97 
some degree of independence (either independently or with assistance from another person 98 
varying from having someone to help them to physically mark their answers to having 99 
someone help them to think about their answers); questionnaires completed entirely by 100 
parental proxy were excluded from analyses). Participants did not participate in any 101 
intervention as part of the study and were not previously enrolled in any type of intervention 102 
within the Stay-FIT program. Participant or parent/caregiver written consent was obtained 103 
before study commencement. The study was approved by the Hamilton Integrated Research 104 
Ethics Board.  105 
 106 
Fatigue 107 
The FISSA is a newly developed fatigue questionnaire that has been validated for use with 108 
youth and adults with CP.17 This new measure comprises 37 items aimed to provide an 109 
overall total fatigue score and information specific to the impact and severity (Impact 110 
Subscale) and the management (Management and Activity Modification Subscale) of 111 
fatigue.17 Responses to the first 31 items are summed to provide the total score (ranging 112 
from 31 (minimum) to 157 (maximum)) and are generally scored on a 5-point Likert scale 113 
from Completely Disagree (1) to Completely Agree (5). A higher score indicates greater 114 
fatigue.17 One question, related to the number of days of the week that fatigue is 115 
experienced, is scored on a 7-point Likert scale. The remaining 6 questions are qualitative in 116 
nature and are not included as part of the FISSA scores.17 The FISSA contains a framing 117 
definition for participants to think about fatigue in terms of physical tiredness, muscle 118 
soreness, exhaustion of your muscles and body or any related feeling. The questionnaire can 119 
be used to promote discussion between individuals with CP and their clinicians about fatigue. 120 
The FISSA was intended to be a clinical tool used at the individual level, to facilitate the 121 
understanding of the individualized nature of fatigue.  Evidence of construct validity of the 122 
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FISSA was provided by the ability to discriminate between groups expected to have more 123 
fatigue based on functional ability and pain experiences. The FISSA demonstrated adequate 124 
test-retest reliability ICC(3,1)=0.74 (95% CI 0.53-0.87).17 125 
 126 
Variables associated with fatigue 127 
All participants were asked to self-report their GMFCS level (GMFCS Self Report 128 
Questionnaire, www.canchild.ca)19, their type of motor impairment (spastic or mixed) and 129 
topographical distribution (unilateral or bilateral), during the initial assessment. Type of motor 130 
impairment (spastic or mixed) and topographical distribution (unilateral or bilateral) were 131 
classified according to the Surveillance of Cerebral Palsy in Europe guidelines.20 Height, 132 
body mass and WC were re-measured by one researcher (PM) at follow-up, during the same 133 
time in which the FISSA was administered. BMI (kg/m2) was calculated, and measurement of 134 
WC was performed supinely at 4 cm above the umbilicus, as previously reported.3  135 
 136 
Statistical analysis 137 
Statistical analyses were performed using STATA (version 13) statistical software. 138 
Descriptive summary statistics were calculated and reported as mean, standard deviation, 139 
minimum, lower quartile, median, upper quartile, and maximum values for each continuous 140 
variable. Nominal data (i.e. topographical distribution, GMFCS level, type of motor 141 
impairment) were reported as percentages. All continuous variables were assessed for 142 
normality using the Shapiro-Wilk descriptive test. A series of paired-samples t-tests were 143 
performed to assess the difference between baseline (T0) and follow-up (T1) time points for 144 
FISSA scores, BMI, and WC. Bivariate correlations were conducted for FISSA scores, BMI, 145 
and WC between the two time points (T0 & T1). Univariate linear regression analyses were 146 
performed to investigate the relationship between change in FISSA scores (dependent 147 
variable) and age, change in FISSA scores and BMI, and change in FISSA scores and WC. 148 
Percent variance attributable to change in FISSA scores within each univariate regression 149 
analysis was tested using an analysis of variance to determine the significance of each 150 
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model. Exploratory analyses were performed via independent-samples t-tests to assess 151 
change in FISSA scores between topographical distributions (unilateral or bilateral) as well 152 
as between community ambulatory (GMFCS I-II) and community non-ambulatory (GMFCS 153 
III-V) participants. As this study was a follow-up to cross-sectional research conducted by 154 
McPhee et al.,3 independent-samples t-tests were conducted between participants and non-155 
participants for variables of FISSA score, age, BMI, and WC. A minimum criterion alpha level 156 
of p-value ≤0.05 was used to determine statistical significance. A Bonferroni correction was 157 
performed to prevent type I error. 158 
 159 
Results 160 
Participants 161 
FISSA questionnaires were completed by 23 (mean age 38y 2m [SD 14y 1m]; min-max 21-162 
78) of the eligible 41 participants. The remaining 18 participants did not respond to our 163 
request to participate. Mean (SD) follow-up period was 3y 8m (5m). A non-responder 164 
analysis showed no difference between responders and non-responders in FISSA score, 165 
age, BMI, or WC (data not shown). Participant characteristics are presented in Table I. Age 166 
was not normally distributed at both time points (p<0.05), therefore natural log 167 
transformations of the data were performed resulting in normal distributions. All other 168 
continuous variables were normally distributed. It was not possible to obtain WC 169 
measurements in four participants at the site of 4 cm above the umbilicus, which was 170 
attributable to the presence of an intrathecal baclofen pump, enteral feeding tube, or other 171 
obscurity (i.e. bandages). In these participants, WC was measured at the border of the 172 
anterior superior iliac crest. In one participant WC was not measured, due to other practical 173 
inconveniences.    174 
 175 
Fatigue 176 
The mean (SD) FISSA score for all participants at T0 was 84 (27.7) and 91.7 (26.7) at T1. 177 
There was no significant difference in mean total FISSA scores between the two time points 178 
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(mean difference=7.74, p=0.087, 95% CI -16.7 to 1.22). The minimum FISSA score at T0 179 
was 34, and 36 at T1. The maximum FISSA score at T0 was 144, and 139 at T1. Overall 180 
mean FISSA scores by GMFCS level are displayed in Figure 1. Individual FISSA scores for 181 
each GMFCS level are depicted in Figure 2.  182 
Variables associated with fatigue 183 
There was no significant difference in BMI between T0 and T1 (mean difference=1.65, 184 
p=0.084, 95% CI -2.54 to 0.24). There was a significant increase in WC in the follow-up 185 
cohort (mean difference=4.10, p=0.016, 95% CI -7.34 to -.084). 186 
Pearson correlation analyses revealed significant associations between FISSA scores at T0 187 
vs. T1 (r=0.71, p<0.001), BMI at T0 vs. T1 (r=0.86, p<0.001), and waist circumference at T0 188 
vs. T1 (r=0.93, p<0.001).  189 
Univariate regression analyses did not reveal any significant relationships between change in 190 
BMI and change in FISSA scores (r=0.376, p=0.077), change in WC and change in FISSA 191 
scores (r=-0.245, p=0.271), or age and change in FISSA scores (r=-0.371, p=0.082). 192 
Exploratory analyses via independent samples t-tests for differences in FISSA scores 193 
between topographical distribution revealed no significant difference between those who 194 
were unilaterally vs. bilaterally affected (p=0.899). Similarly, there was no significant 195 
difference in FISSA scores between those who were community ambulatory (GMFCS I-II) 196 
versus community non-ambulatory (GMFCS III-V) (p=0.341).   197 
 198 
Discussion 199 
The primary objective of this study was to describe the course of fatigue, using the FISSA, 200 
over a 3-year time period in adults with CP. At the group level, mean FISSA scores were not 201 
statistically significantly different between baseline and follow-up time points. Secondary 202 
objectives were to investigate relationships between demographical characteristics and body 203 
composition and changes in FISSA scores over time. Potential determinants (WC and BMI) 204 
were tested as predictors of change in FISSA scores over time, as was previously concluded 205 
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in the study by McPhee et al.3 In this study, we did not find changes in BMI or WC to be 206 
predictive of changes in FISSA scores. This is likely attributable to the wide range of absolute 207 
changes in BMI (min-max 0-14.6 kg/m2), WC (min-max 0.5-17 cm), and FISSA scores (min-208 
max 4-50), as well as the small sample size in the present study. Russchen et al.5 found 209 
participants with bilateral CP to be more at risk for fatigue. We did not find a statistical 210 
difference in FISSA change in the topographical distribution in this study. Whether or not 211 
topographical distribution contributes to fatigue in adults with CP remains to be determined in 212 
a larger sample. 213 
We were also interested in describing changes in FISSA scores at the subgroup (within each 214 
GMFCS level) and individual levels. Similar to findings by McPhee et al.,3 our follow-up 215 
findings suggest that fatigue may be associated with GMFCS level, with GMFCS level II as 216 
being the exception (Fig. 1). In GMFCS level II we found a higher FISSA score than levels I 217 
and III. Those classified as GMFCS level II may experience difficulty walking long distances 218 
on uneven terrain, and may walk with physical assistance or a handheld mobility device.21 219 
We know from a study by Balemans et al.,22 in children and adolescents with CP (n=57), that 220 
23% of participants in GMFCS level I; 47% of participants in GMFCS level II; and 71% in 221 
GMFCS level III showed a VO2walk that was higher than their anaerobic threshold. At 222 
intensities above the anaerobic threshold one becomes exhausted quickly and muscles 223 
become sore and painful and therefore might contribute to fatigue, which might explain the 224 
increase in fatigue in GMFCS level II in the present study. This could be of interest for future 225 
research.  226 
In the current study, the GMFCS level III group was the only one to exhibit a decrease in total 227 
FISSA score, albeit non-significant. As mentioned in the study of McPhee et al.3 and also in 228 
the study above,22 it is likely that those who function at GMFCS level III and use arm 229 
crutches and/or a manual wheelchair may experience greater fatigue. However, GMFCS 230 
level III is a subgroup of individuals with a great variation in mobility, depending on their 231 
physical abilities and personal/environmental factors. An individual could, for example, have 232 
made an effort to keep climbing the stairs, but decided to stop doing that, which could 233 
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potentially have a positive effect on their fatigue. A previous study23 described the probability 234 
of walking among children with CP. They concluded that the probability of walking, in children 235 
classified as GMFCS level III, was highest at age 9 (68%) and the probability of walking at 236 
age 18 was approximately 50%. For adults, this specific probability of walking is unknown. 237 
Opheim et al.9 found 78% of participants in GMFCS level III (n=23) to have reported a 238 
deteriorated walking function over time. This variation in physical abilities and change in 239 
assisted mobility over time is less likely to occur in other GMFCS levels, and might therefore 240 
explain the decreased FISSA score in level III. It also reflects on individual variability within 241 
the population and within the GMFCS levels, which makes it hard to give a generalizable 242 
conclusion with the small sample size in our study.  243 
On an individual level there are major changes found, for example in one participant the 244 
FISSA score changed from 144 to 109, with a BMI decrease from 50 to 43 kg/m2. In another 245 
participant the FISSA score increased from 89 to 139 and BMI changed from 13 to 28 kg/m2. 246 
Both cases seem to reveal a relationship between BMI and FISSA score. Overall, 35% of 247 
participants were found to be obese at T1 (defined24 as a BMI ³30 kg/m2) versus 30% at T0. 248 
Central obesity (WC ³88 cm for females or ³102 cm for males24) was found in 32% (T1) 249 
versus 36% (T0). In a previous study,5 WC has been considered a more sensitive parameter, 250 
as compared to BMI, and as being predictive for fatigue. For future research, more insight is 251 
needed in the relationship between BMI/WC and fatigue by use of a gold standard measure 252 
of body composition (i.e. dual energy x-ray absorptiometry) in order to differentiate which 253 
should be used, as the best (and most practical) indicator for body composition, in individuals 254 
with CP.  255 
The current study underscores the importance of the use of the FISSA for surveillance of 256 
fatigue in clinical practice and the importance of promoting discussion between clinicians and 257 
their patients about fatigue. An important clinical implication of the results here is that adults 258 
with CP that experience fatigue, are likely to still experience fatigue 3 years later. Moreover, 259 
there is great value associated with preventing the development or worsening of fatigue to 260 
maximize functional abilities and avoid deterioration with age. Care providers should 261 
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consider educating patients about fatigue, helping (young) adults to cope with fatigue and 262 
discuss risk factors that might be modifiable (i.e. body mass).  263 
 264 
Study limitations 265 
While a strength of this study is the use of a fatigue questionnaire (FISSA) that has been 266 
validated in adults with CP, there are some factors that should be taken into consideration 267 
while interpreting our findings. Of note, we took advantage of the opportunity to follow-up 268 
with a cohort that was previously recruited for a cardiovascular study3 through purposeful 269 
sampling aimed at more or less equal representation at each GMFCS level. Therefore our 270 
sample is not a population based sample in which a higher proportion of people would have 271 
been expected in GMFCS level I. The response rate was reasonable (56%), with no 272 
evidence of systematic selection bias, leaving us with 23 participants representing all 273 
GMFCS levels for analysis of change in FISSA scores. To re-test our primary objective, that 274 
the relationship between FISSA scores and time is greater than zero (i.e. two-tailed; p-value 275 
≤0.05), with 0.8 power, a sample size of 59 is required. Nevertheless, our study is the first 276 
longitudinal study that provides valuable information about stability of FISSA scores over 277 
time in 23 adults with CP.      278 
Secondly, we do not yet know the minimal clinically important difference (MCID) of the 279 
FISSA. To our knowledge, our study is the first to describe a follow-up of fatigue in adults 280 
with CP using the FISSA, a fatigue tool validated in this population, and including all levels of 281 
the GMFCS. Future studies should consider multi-centre studies with large samples to gain a 282 
better understanding of the evaluative capacity and MCID of the FISSA. 283 
Thirdly, we understand that waist circumference can be measured using different techniques 284 
and there are various ways to measure body composition. Future studies should consider 285 
developing a standard outcome set for body composition.  286 
 287 
Conclusion 288 
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The results of this study indicate that fatigue remains an ongoing challenge for adults with 289 
CP inclusive of all five levels of the GMFCS, with a variable presentation between 290 
individuals. We did not find age or body composition (i.e. BMI, WC) to be predictive of 291 
change in FISSA scores. However, the clinically important implication of our study is that 292 
adults with CP who experience fatigue, are likely to remain fatigued in the future. We would 293 
therefore advise care providers to monitor and talk about fatigue with adults with CP. To 294 
attenuate fatigue later in life, we would suggest to begin the discussion with younger people 295 
with CP.  296 
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 373 
 374 
Table I: Participant classifications and characteristics 
Characteristic Total (n=23) 
Sex, n (%)  
  Males 9 (39) 
  Females 14 (61) 
Type, n (%)  
  
Spastic 
CP 17 (74) 
  
Mixed 
CP 6 (26) 
Distribution, n (%)  
  
Unilateral 
CP 7 (30) 
  
Bilateral 
CP 16 (70) 
GMFCS, n (%)  
  I 4 (17) 
  II 5 (22) 
  III 5 (22) 
  IV 6 (26) 
  V 3 (13) 
Characteristic T0 – T1 Mean T0 (SD) Mean T1 (SD) Min. T0 Min. T1 Max. T0 Max. T1 
Age, y 34.6 (14.2) 38.2 (14.1) 18.0 21.0 75.0 78.0 
BMI, kg/m2 26.1 (8.4) 27.8 (8.1) 13.3 15.7 50.0 42.6 
Waist circumference, cma 83.5 (21.1) 87.6 (20.1) 54.0 56.0 142.0 135.0 
FISSA scores 84.0 (27.7) 91.7 (26.7) 34.0 36.0 144.0 139.0 
an=22, due to 1 missing measurement. 375 
Mixed CP consisted of a combination of spastic motor disorder and either dyskinetic or ataxic motor disorder. 376 
CP, cerebral palsy; GMFCS, Gross Motor Function Classification System; SD, standard deviation; Min., minimum; 377 
Max., maximum; BMI, body mass index; FISSA, Fatigue Impact and Severity Self-Assessment.  378 
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Figure 1: ‘Oude Lansink Figure 1.pdf’ 380 
 381 
 382 
Figure 1. Mean (SD) Fatigue Impact and Severity Self-Assessment (FISSA) scores at each Gross 383 
Motor Function Classification System (GMFCS) level at T0, baseline; and T1, follow-up.  384 
 385 
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 387 
Figure 2: ‘Oude Lansink Figure 2.pdf’ 388 
 389 
 390 
Figure 2. Change in Fatigue Impact and Severity Self-Assessment (FISSA) score per participant 391 
(between the two time points), categorized per Gross Motor Function Classification System (GMFCS) 392 
level, including mean FISSA score per GMFCS level. Each solid line represents one participant, and 393 
the dashed line represents the mean FISSA score per GMFCS level. T0, baseline; T1, follow-up.  394 
 395 
